Vishnu Chemicals Limited (NSE:VISHNU)

Market Cap	32.12B
Revenue (ttm)	14.55B
Net Income (ttm)	1.28B
Shares Out	n/a
EPS (ttm)	19.37
PE Ratio	25.02
Forward PE	19.29
Dividend	0.30 (0.06%)
Ex-Dividend Date	Aug 8, 2025

Volume	123,131
Average Volume	591,277
Open	472.65
Previous Close	477.75
Day's Range	468.35 - 481.00
52-Week Range	336.00 - 595.80
Beta	-0.13
RSI	39.16
Earnings Date	Aug 11, 2025

About Revance Therapeutics

Vishnu Chemicals Limited engages in the manufacture and sale of chromium chemicals in India. The company offers chromium chemicals, such as sodium dichromate, basic chromium sulphate, chromic acid, chrome oxide green, white sodium sulphate, and potassium dichromate; and barium barium carbonate, precipitated barium sulphate, and sodium sulphide. Its products are used in pharmaceuticals, consumer goods, glass, pigments and dyes, leather, automobiles, and wood preservatives markets. The company also supplies its products to Asia, China, South East...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1989
• Employees: 490
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VISHNU

Financial Performance

In 2024, Vishnu Chemicals's revenue was 14.47 billion, an increase of 19.29% compared to the previous year's 12.13 billion. Earnings were 1.27 billion, an increase of 25.26%.